healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Protocols
medication-ranolazine-twice-daily-generic
Outcomes
01
survival-mortality-cardiovascular-ventricular-tachycardia-or-fibrillation-first-occurrence-binary-measured
1 evidence row
zareba_2018_rct_ranolazine-in-high-risk-implantable-cardioverter-defibrillator-patients-raid-trial
02
survival-mortality-cardiovascular-ventricular-tachycardia-recurrent-episodes-count-cohort-measured
1 evidence row
zareba_2018_rct_ranolazine-in-high-risk-implantable-cardioverter-defibrillator-patients-raid-trial
healthprotocol.wiki